SIRT2 and Huntington disease: In contrast to this, another study showed that a reduction in SIRT2 had no effect on the tubulin acetylation, cholesterol biosynthesis and failed to modulate disease progression in the R6/2 mouse model of HD (Bobrowska et al., 2012).